Hemo Organic Stock Price Analysis and Quick Research Report. Is Hemo Organic an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Hemo Organic. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Hemo Organic has a PE ratio of 46.1438474870017 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Hemo Organic has ROA of -46.8512% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Hemo Organic has a Current ratio of 6.6398.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Hemo Organic has a ROE of 0%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Hemo Organic has a Debt to Equity ratio of -3.9242 which means that the company has low proportion of debt in its capital.

• Sales growth: Hemo Organic has reported revenue growth of 366.6667% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Hemo Organic for the current financial year is -1089.28571428571%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Hemo Organic is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Hemo Organic is Rs 0.2308. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Hemo Organic in Ticker for free. Also, one can get the intrinsic value of Hemo Organic by using Valuation Calculators, which are available with a Finology ONE subscription. 

Hemo Organic FAQs

Q1. What is Hemo Organic share price today?
Ans: The current share price of Hemo Organic is Rs 10.65.

Q2. What is the market capitalisation of Hemo Organic?
Ans: Hemo Organic has a market capitalisation of Rs 3.6911835 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Hemo Organic?
Ans: The PE ratio of Hemo Organic is 46.1438474870017 and the P/B ratio of Hemo Organic is -15.484152369875, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Hemo Organic share?
Ans: The 52-week high share price of Hemo Organic is Rs 14.65, and the 52-week low share price of Hemo Organic is Rs 8.05.

Q5. Does Hemo Organic pay dividends?
Ans: Currently, Hemo Organic does not pay dividends. Dividend yield of Hemo Organic is around 0%.

Q6. What are the face value and book value of Hemo Organic shares?
Ans: The face value of Hemo Organic shares is Rs 10, while the book value per share of Hemo Organic is around Rs -0.6878. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Hemo Organic?
Ans: Hemo Organic has a total debt of Rs 1.2377 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Hemo Organic?
Ans: The ROE of Hemo Organic is 0% and ROCE of Hemo Organic is -53.8012%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Hemo Organic a good buy for the long term?
Ans: The Hemo Organic long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Hemo Organic undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Hemo Organic appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Hemo Organic’s financials?
Ans: You can review Hemo Organic’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.